Table 3.

Cox regression model B for predicting all-cause mortality.

	Male, p < 0.001		Female, p < 0.001		All, p < 0.001
	HR (95 % CI)	p value	HR (95 % CI)	p value	HR (95 % CI)	p value
Septal Thickness /BSA	1.04 (1.01-1.07)	0.005	1.05 (1.02-1.08)	0.002	1.04 (1.02-1.06)	< 0.001
Age	1.06 (1.05–1.06)	< 0.001	1.05 (1.05–1.06)	< 0.001	1.05 (1.05–1.05)	< 0.001
Hypertension	1.14 (1.07–1.23)	< 0.001	1.13 (1.06–1.2)	< 0.001	1.13 (1.08–1.18)	< 0.001
Dyslipidaemia	0.82 (0.77–0.88)	< 0.001	0.9 (0.85–0.97)	0.006	0.86 (0.82–0.91)	< 0.001
Diabetes	1.59 (1.49–1.69)	< 0.001	1.47 (1.37–1.57)	< 0.001	1.54 (1.46–0.61)	< 0.001
IHD	0.91 (0.85–0.97)	0.006	1.08 (1–1.18)	0.05	0.97 (0.96–1.02)	0.23
Atrial fibrillation	1.09 (1–1.18)	0.046	1.04 (0.96–1.13)	0.3	1.06 (1–1.12)	0.33
CHF	1.5 (1.38–1.63)	< 0.001	1.61 (1.48–1.75)	< 0.001	1.56 (1.47–1.65)	< 0.001
LVM /BSA	0.99 (0.99–0.99)	0.001	1 (0.99–1)	0.52	0.99 (0.99–1)	0.19
LVEDd /BSA	1.01 (0.99–1.03)	0.2	0.96 (0.95–0.98)	< 0.001	0.98 (0.97–0.99)	0.006
LVESd /BSA	1.02 (1–1.04)	0.006	1.02 (1–1.03)	0.03	1.02 (1.01–1.03)	< 0.001
Ejection fraction	0.991 (0.987–0.995)	< 0.001	0.98 (0.98–0.99)	< 0.001	0.98 (0.98–0.99)	< 0.001
LA volume /BSA	1.007 (1.005–1.009)	< 0.001	1.008 (1.006–1.01)	< 0.001	1.007 (1.006–1.009)	< 0.001
AS ≥ moderate	1 (0.89–1.13)	0.87	1.05 (0.94–1.18)	0.4	1.03 (0.95–1.12)	0.46
MR ≥ moderate	0.93 (0.82–1.06)	0.93	1.05 (0.92–1.19)	0.47	0.99 (0.9–1.09)	0.89

HR, hazard ratio; CI, confidence interval; IHD, ischaemic heart disease; CHF, congestive heart failure;

LVM, left ventricular mass; BSA, body surface area; LVEDd, left ventricular end diastolic diameter; LVESd, left ventricular end systolic diameter; LA, left atrium; AS, aortic stenosis; MR, mitral regurgitation;